Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/26/2025

Propranolol Dosage and Administration

Introduction to Propranolol

  • The British Journal of Dermatology recommends a starting dose of 1 mg/kg/day, a maintenance dose of 2 mg/kg/day for uncomplicated patients, and a maximum dose of 3 mg/kg/day for non-responders, with administration divided into 2-3 daily doses 1
  • The maximum dose can also be supported by Pediatrics, which also recommends a maximum dose of 3 mg/kg/day for non-responders 2

Special Populations

  • For patients with PHACES syndrome, the British Journal of Dermatology recommends starting at 0.5 mg/kg/day 1
  • For premature or low-weight infants, the British Journal of Dermatology suggests using more cautious dosing 1

Administration Considerations

  • According to Pediatrics, propranolol should be administered with or after feeding to reduce the risk of hypoglycemia in infantile hemangioma patients, and doses should be held during times of diminished oral intake or vomiting 2
  • The British Journal of Dermatology recommends using a 5 mg/5 mL preparation for infantile hemangioma administration 1

Contraindications and Pretreatment Assessment

  • The British Journal of Dermatology lists contraindications including hypoglycemic episodes, second or third-degree heart block, hypersensitivity to propranolol, and asthma or obstructive airway disease 1
  • Circulation also lists asthma or obstructive airway disease as a contraindication 4
  • The British Journal of Dermatology and Praxis Medical Insights recommend a pretreatment assessment including cardiovascular and respiratory examination, and ECG and ECHO in selected cases 1, 3

Common Side Effects

  • Circulation reports common side effects including hypotension, bradycardia, and precipitation of heart failure 4
  • Pediatrics also reports sleep disturbances as a common side effect 2

Discontinuation

  • The British Journal of Dermatology recommends that propranolol can be stopped abruptly at 1 year of age for infantile hemangioma patients 1